RenovoRx financials
$1.57+1.29%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $909.0K | $563.0K | $238.0K | $266.0K | $422.0K | $197.0K | $43.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross profit | $766.0K | $479.0K | $210.0K | $213.0K | $270.0K | $103.0K | $43.0K | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross margin | 84.3% | 85.1% | 88.2% | 80.1% | 64.0% | 52.3% | 100.0% | — | — | — | — | — |
| Operating income | -$3.3M | -$3.5M | -$3.5M | -$3.2M | -$2.7M | -$3.1M | -$2.6M | -$2.8M | -$3.0M | -$2.5M | -$1.8M | -$3.0M |
| Net income | -$2.9M | -$3.5M | -$2.9M | -$2.9M | -$2.9M | -$2.4M | -$2.9M | -$2.5M | -$2.4M | -$1.1M | -$3.2M | -$1.4M |
| Net margin | −320.2% | −625.4% | −1235.7% | −1094.7% | −686.0% | −1228.4% | −6693.0% | — | — | — | — | — |
| Diluted EPS | $-0.06 | $-0.09 | $-0.08 | $-0.08 | $-0.08 | $-0.08 | $-0.11 | $-0.10 | $-0.10 | $-0.07 | $-0.30 | $-0.13 |
| EBITDA | -$3.3M | -$3.5M | -$3.5M | -$3.2M | -$2.7M | -$3.1M | -$2.6M | -$2.8M | -$3.0M | -$2.5M | -$1.8M | -$3.0M |
| Operating cash flow | -$2.9M | -$3.7M | -$3.0M | -$2.3M | -$2.3M | -$3.4M | -$2.4M | -$2.2M | -$2.3M | -$2.2M | -$2.1M | -$2.7M |
| Free cash flow | -$2.9M | -$3.7M | -$3.0M | -$2.3M | -$2.3M | -$3.4M | -$2.4M | -$2.2M | -$2.3M | -$2.2M | -$2.1M | -$2.7M |
| Diluted shares | 47.3M | 38.0M | 36.7M | 36.6M | 36.6M | 31.4M | 25.1M | 24.9M | 24.0M | 14.9M | 10.7M | 10.7M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $9.5M | $12.4M | $7.0M | $10.0M | $12.3M | $14.6M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $11.5M | $14.0M | $8.1M | $11.2M | $13.6M | $16.0M |
| Total liabilities | $2.5M | $2.7M | $2.7M | $3.1M | $3.0M | $2.9M |
| Shareholders' equity | $9.0M | $11.3M | $5.4M | $8.1M | $10.6M | $13.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology